Bank of New York Mellon’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Buy |
159,093
+15,428
| +11% | +$363K | ﹤0.01% | 2425 |
|
|
2025
Q1 | $3.45M | Buy |
143,665
+1,717
| +1% | +$41.2K | ﹤0.01% | 2407 |
|
|
2024
Q4 | $6M | Buy |
141,948
+7,895
| +6% | +$334K | ﹤0.01% | 2187 |
|
|
2024
Q3 | $5.93M | Sell |
134,053
-31,269
| -19% | -$1.38M | ﹤0.01% | 2212 |
|
|
2024
Q2 | $5.98M | Buy |
165,322
+9,854
| +6% | +$357K | ﹤0.01% | 2245 |
|
|
2024
Q1 | $6.7M | Buy |
155,468
+24,150
| +18% | +$1.04M | ﹤0.01% | 2175 |
|
|
2023
Q4 | $2.02M | Buy |
131,318
+3,086
| +2% | +$47.5K | ﹤0.01% | 2827 |
|
|
2023
Q3 | $1.76M | Sell |
128,232
-1,975
| -2% | -$27.1K | ﹤0.01% | 2880 |
|
|
2023
Q2 | $2.09M | Buy |
130,207
+32,227
| +33% | +$517K | ﹤0.01% | 2805 |
|
|
2023
Q1 | $760K | Buy |
97,980
+26,210
| +37% | +$203K | ﹤0.01% | 3259 |
|
|
2022
Q4 | $1.39M | Buy |
71,770
+2,272
| +3% | +$44K | ﹤0.01% | 3040 |
|
|
2022
Q3 | $1.48M | Sell |
69,498
-5,586
| -7% | -$119K | ﹤0.01% | 3013 |
|
|
2022
Q2 | $1.02M | Buy |
75,084
+26,248
| +54% | +$357K | ﹤0.01% | 3199 |
|
|
2022
Q1 | $1.15M | Buy |
48,836
+28,247
| +137% | +$663K | ﹤0.01% | 3225 |
|
|
2021
Q4 | $550K | Buy |
20,589
+7,365
| +56% | +$197K | ﹤0.01% | 3744 |
|
|
2021
Q3 | $230K | Buy |
+13,224
| New | +$230K | ﹤0.01% | 4144 |
|